TriSalus Life Sciences
Stock Forecast, Prediction & Price Target
TriSalus Life Sciences (TLSI) stock Price Target by analysts
$10.5
Potential upside: 125.80%
TriSalus Life Sciences price prediction
What is TriSalus Life Sciences stock analysts` prediction?
TriSalus Life Sciences stock forecast: Based on 2 Wall Street analysts` predicted price targets for TriSalus Life Sciences in the last 3 months, the avarage price target is $10.5, with a high forecast of $NaN. The average price target represents a 125.80% change from the last price of $4.65.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
TriSalus Life Sciences stock Price Target by analysts
Full breakdown of analysts given TriSalus Life Sciences price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
William Plovanic Canaccord Genuity | 0% 0/2 | 10 months ago | $11 136.55% upside | $4.11 | StreetInsider | Previous targets (1) |
Suraj Kalia Oppenheimer | 0% 0/1 | 12 months ago | $10 115.05% upside | $4.52 | StreetInsider | Previous targets (0) |
William Plovanic Canaccord Genuity | 0% 0/2 | about 1 year ago | $12 158.06% upside | $5.33 | StreetInsider | Previous targets (1) |
TriSalus Life Sciences Financial Estimates
TriSalus Life Sciences Revenue Estimates
TriSalus Life Sciences EBITDA Estimates
TriSalus Life Sciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $8.40M N/A | $12.39M 47.57% | $18.51M 49.30% | Avg: $43.40M Low: $36.02M High: $48.28M avg. 134.49% | Avg: $60.00M Low: $52.32M High: $65.51M avg. 38.22% | ||
Net Income
% change YoY
| $-28.84M N/A | $-47.18M -63.58% | $-59.03M -25.11% | Avg: $-44.57M Low: $-14.37M High: $-10.99M avg. 24.49% | Avg: $-54.31M Low: $-20.20M High: $-8.83M avg. -21.84% | ||
EBITDA
% change YoY
| $-22.82M N/A | $-44.59M -95.39% | $-58.29M -30.73% | Avg: $-43.40M Low: $-48.28M High: $-36.02M avg. 25.54% | Avg: $-60.00M Low: $-65.51M High: $-52.32M avg. -38.22% | ||
EPS
% change YoY
| -$0.92 N/A | -$1.59 -72.82% | -$6.73 -323.27% | Avg: -$1.3 Low: -$1.53 High: -$1.17 avg. 80.63% | Avg: -$1.35 Low: -$2.15 High: -$0.94 avg. -3.32% | ||
Operating Expenses
% change YoY
| $31.24M N/A | $46.57M 49.10% | $70.05M 50.40% | Avg: $93.90M Low: $77.93M High: $104.45M avg. 34.03% | Avg: $129.79M Low: $113.18M High: $141.71M avg. 38.22% | ||
FAQ
What is TriSalus Life Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 1.32% in 2025-2026.
We have gathered data from 3 analysts. Their low estimate is -14.37M, average is -44.57M and high is -10.99M.
What is TriSalus Life Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 86.36% in 2025-2026.
We have gathered data from 3 analysts. Their low revenue estimate is $36.02M, average is $43.40M and high is $48.28M.
What is TriSalus Life Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 38.65% in 2025-2026.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.53, average is -$1.3 and high is $-1.17.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering TriSalus Life Sciences stock. The most successful analyst is William Plovanic.